TD Cowen analyst Ryan Langston lowered the firm’s price target on Universal Health (UHS) to $251 from $275 and keeps a Buy rating on the shares. The firm said UHS is a best idea for 2025. The incoming administration and market sentiment add risk to the pick and acknowledge the potential for revisions to entitlement programs and other headwinds.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target lowered to $230 from $285 at Wells Fargo
- BofA shakes up ratings of healthcare stocks following Trump win
- Five Below downgraded, Snowflake upgraded: Wall Street’s top analyst calls
- Universal Health downgraded to Neutral at BofA after Trump win
- Universal Health downgraded to Neutral from Buy at BofA